RecruitingNCT03973268
Brain changes linked to ketamine in treatment-resistant depression
About this title
Read the official source — NCT03973268Medication studyAges 18–70United States
Understand this study
Who could participate?
This study is for people with depression. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: January 21, 2020
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 70
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Device, Drug, Other
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT03973268
- Official title
Show the full official title
The Mechanism of Action Underlying Ketamine's Antidepressant Effects: An Investigation of the AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Who can participate?
This study is for people with depression. Listed age limits: 18 years to 70 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
